Saint Luke's will 'triple' access to NCI trials with new affiliation

Saint Luke's Health System will broaden its cancer clinical trials through an affiliation with Washington University in St. Louis. "It expands the number and the breadth of the available trials that we will be able to offer to our patients here," said Timothy Pluard, director of Saint Luke's Cancer Institute. "It essentially for us is about tripling the number of NCI clinical trials that we'll have access to." Through the ag reement, Saint Luke's will be affiliated with Washington University's Siteman…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news